Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 9.3B | 8.8B | 8.8B | 8.7B |
Cost of revenue | 7.7B | 7.3B | 7.4B | 7.3B |
Gross profit | 1.6B | 1.5B | 1.4B | 1.4B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 200.3M | 180M | 184.7M | 167.9M |
Operating income | 573M | 531.6M | 498.1M | 531.4M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 196.2M | 198.9M | 207.7M | 197.6M |
Other income expense | — | — | — | — |
Pretax income | 406.4M | 392.5M | 317.9M | 362.4M |
Tax provision | 98.9M | 105.5M | 88.6M | 89.9M |
Net income | 307.5M | 287M | 229.3M | 272.5M |
Basic EPS | — | 2.4 | 2 | 2.4 |
Diluted EPS | — | 2.4 | 2 | 2.4 |
Basic average shares | — | 117.6M | 114.6M | 114.5M |
Diluted average shares | — | 117.6M | 114.6M | 114.5M |
EBITDA | 803.2M | 792.1M | 726.1M | 755.5M |
Net income from continuing op. | — | — | — | — |
Minority interests | 0 | 0 | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |